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ABSTRACT: The chromatographic separation of the components of the acetone extract of 
Mallotus philippensis fruits yielded five new phenolic compounds including two chalcones 1 and 
3, a functionalized phloroglucinol 2, two flavanones 4 and 5 and six known compounds. The 
structures of 15 were confirmed by NMR and mass analyses. Racemic compounds 1 and 2 were 
separated by chiral-phase HPLC and the absolute configuration of (+)-1 was confirmed by X-ray 
diffraction studies and ECD spectroscopic data. The configurations of the enantiomers of 2 were 
defined by comparison of its ECD data with those of (+)-1. Compounds 6 and 7 exhibited 
significant antibacterial activities with MIC values ranging from 3.8 to 15.5 μM. 
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Mallotus philippensis (Euphorbiaceae), known locally in Thai as ‘‘Kham Saet’’, is a perennial 
shrub or small tree that is widely distributed from East to Southeast Asia, Indomalaysia to New 
Caledonia, and in Australia.1,2 Glandular hairs of the fruits are covered with short soft curved 
reddish bristles which are a source of rottlerin.3 This plant has long been used for its anthelmintic 
and purgative properties.4,5 In Northern Thailand, the fruits and bark have been used in traditional 
medicine and as a dye.2  Several types of bioactive compounds have been isolated from the fruits 
which have displayed a range of pharmacological activities including anti-allergic,6 anti-
inflammatory,6 antifungal,7 and antimycobacterial activities.8,9 Rottlerin, a red powder from the 
fruits, exhibits an inhibitory effect towards protein kinase C.10 As part of a search for bioactive 
compounds from Thai medicinal plants, the acetone extract of M. philippensis fruits was screened 
for antibacterial activity and afforded two new chalcones 1 and 3, a new functionalized 
phloroglucinol 2, two new flavanones 4 and 5, and six known flavonoids (Chart 1). The known 
compounds were identified as rottlerin (6),11 4'-hydroxyrottlerin (7),7 isorottlerin (8),11 4'-
hydroxyisorottlerin (9),11 isoallorottlerin (10),11 and mallotophilippen F (11)8. Some isolates were 
also tested for their antibacterial activities. 
RESULTS AND DISCUSSION 
Compound 1, racemic orange crystals, had the formula C30H34O4, as indicated by 
HRESIMS (m/z 458.2452, [M]+) and 13C NMR data, consistent with an index of hydrogen 
deficiency of 14. The UV absorption bands [λmax 236, 307, and 351 nm] were attributed to 
conjugated chromophores and its IR spectrum showed absorption bands for a hydroxy (3327 cm-
1), and conjugated hydrogen bonded carbonyl (1691 cm-1) groups. Its 1H and 13C NMR 
spectroscopic data (Table 1) indicated the presence of resonances for a hydrogen-bonded hydroxy 
group [H 14.39 (1H, s)], a 3,3-dimethylallyl group [H 5.21 (1H, br t, J = 7.0 Hz), 3.25 (2H, m), 
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1.79 (3H, s), 1.67 (3H, s); C 123.2, 21.3, 17.9, 25.8, 130.9] and an (E)-cinnamoyl unit [H 8.12 
and 7.77 (each 1H, d, J = 15.6 Hz), 7.38-7.60 (5H, m); C 128.0, 141.4, 128.9 (2), 128.8, 128.3 
(2)]. The resonances at H 2.84 (1H, brs, H-7), 2.25 (1H, dt, J = 12.8, 3.5 Hz, H-8a), 2.04 (1H, 
m, H-13), 1.89 (1H, dd, J = 12.8, 1.1 Hz, H-8b), 1.85 (1H, m, H-11a), 1.46 (1H, m, H-11b), 1.33 
(1H, m, H-12a) and 0.92 (1H, m, H-12b) indicated a sequence of aliphatic methine and methylene 
coupled protons of a CH2CHCHCH2CH2 backbone from analysis of the COSY spectrum 
(Figure 1). Three methyl singlets [H 1.56 (Me-16), 1.53 (Me-10) and 1.08 (Me-15)] were also 
observed. The 3,3-dimethylallyl and cinnamoyl moieties were linked to C-3 and C-1, respectively, 
based on the correlations in the HMBC data of OH-2 to C-1 (C 106.5), C-2 (C 163.8), and C-3 
(C 11.5), of H-18 to C-1, and of H-1 to C-2, C-3, and C-4 (C 161.1) (Figure 1). The key HMBC 
correlation between Me-10 and C-8 (C 35.3), C-9 (C 29.1), and C-11 (C 37.6) indicated that 
Me-10 was attached to C-9. The Me-15 and Me-16 groups were located at C-14 based on cross-
peaks in the HMBC data of both methyl groups to C-13 (C 46.0) and C-14 (C 84.9). From these 
HMBC and COSY correlations, a cyclohexane moiety was attached through C-9 and C-13 of the 
two 3,4-dihydro-2H-pyran moieties. Cross-peaks of H-7/H-8a, H-13, and Me-16, and of H-8a/H-
8b and Me-10 (Figures 2 and S7, Supporting Information) in the NOESY spectrum indicated that 
these protons were cofacial. The E-configuration of the Δ18(19) double bond was defined by the 
magnitude of J18,19 (15.6 Hz). Additionally, resolution of compound 1 using semi-preparative 
chiral-phase HPLC (Figure S9, Supporting Information) afforded the two enantiomers of (+)-1 (tR 
12.5 min), [𝛼]D
24 +28.4 (c 0.03, CHCl3) and (−)-1 (tR 14 min), [𝛼]D
24 −24.6 (c 0.03, CHCl3). A 
single crystal was obtained and the (7S,9S,13R) configuration of enantiomer (+)-1 (Figure 3) was 
defined by X-ray diffraction data. The ECD curve of (+)-1 gave positive Cotton effects at 245 and 
304 nm and negative Cotton effects at 224 and 363 nm, whereas (−)-1 had opposite Cotton effects 
 
 
5 
 
at the aforementioned wavelengths (Figure 4). Therefore, the structures of (+)-mallopenin A [(+)-
1] and (−)-mallopenin A [(−)-1] were assigned as shown in Chart 1.  
Compound 2, a racemic pale yellow solid, was assigned a molecular formula, C23H30O4 
from the HRESIMS ion at m/z 371.2216 [M + H]+ (calcd for 371.2222) and 13C NMR data. The 
UV absorptions [λmax 217, 302, and 354 nm] were indicative of a phenyl ring with a carbonyl 
group and the IR absorption bands implied the stretching bands of hydroxy (3282 cm-1) and 
hydrogen bonded carbonyl groups (1713 cm-1). The NMR data of 2 (Table 1) were comparable to 
those of 1. The major difference was that the cinnamoyl moiety of 1 was replaced by an acetyl 
unit, which was evident from resonances at H 2.61 (3H, s)/C 32.7 and 202.8. The position of this 
substituent was determined from HMBC analysis (Figures 2 and S15, Supporting Information) 
from Me-18 to C-1 (C 106.1) and C-17 (C 202.8). Compound 2 was also resolved by chiral-
phase HPLC (Figure S18, Supporting Information) to yield (+)-2 [tR 13.0 min, [𝛼]D
24 +17.4 (c 0.02, 
CHCl3) and (−)-2 [tR 13.5 min, [𝛼]D
24 −11.8 (c 0.02, CHCl3)]. The absolute configurations of 
(7S,9S,13R) for (+)-2 and (7R,9R,13S) for (−)-2 were defined by comparing its ECD spectra 
(Figure 4) with those of (+)-1 and (−)-1, respectively. Thus, the structures of (+)-mallopenin B 
[(+)-2] and (−)-mallopenin B [(−)-2] were defined as shown in Chart 1.  
Compound 3, a pale yellow solid, was assigned a molecular formula, C30H34O4 based on 
its HRTOFESIMS ([M + H]+ at m/z 459.2505) and 13C NMR data. Its UV and IR spectra also 
resembled those of 1.  The NMR spectroscopic data of 3 suggested high structural similarities 
compared to 1 (Table 1, Figures S19 and S20, Supporting Information), indicating that compound 
3 had the same a 3,4-dihydro-2H-benzopyran framework as 1 with the 3,3-dimethylallyl and  
cinnamoyl substituents at C-3 and C-1, respectively. A major difference was found in the NMR 
spitting patterns for the aliphatic methine and methylene resonances [H 3.00 (1H, d, J = 10.7 Hz, 
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H-7), 2.60 (1H, dd, J = 10.7, 8.1 Hz, H-8), 2.34 (1H, brt, J = 8.1 Hz, H-13), 2.04 (1H, m, H-11a), 
1.67 (2H, m, H-11b, H-12a), 1.58 (1H, m, H-12b), 1.41 (3H, s, Me-10), 1.29 (3H, s, Me-16), 0.70 
(3H, s, Me-15); C 34.7, 36.5, 45.2, 37.6, 24.8, 26.7, 32.6, 16.8]. The singlet resonance at H 6.00 
(1H, s) was assigned to a hydroxy group due to its lack of a cross peak in the HMQC experiment. 
However, this resonance showed cross-peaks in the HMBC spectrum (Figure 1) with C-3 (C 
104.6), C-4 (C 159.5), and C-5 (C 102.4). The connectivity of H-7/H-8, H-11/H-12, H-12/H-13 
and H-13/H-8 in the COSY spectrum led to assignment of all aliphatic protons. The gem-dimethyl 
moiety was located at C-14 based on cross peaks in the HMBC spectrum from Me-15 to C-7 (C 
34.7), C-13 (C 45.2), C-14 (C 38.2), and C-16 (C 32.6), from H-7 to C-8 (C 36.5), C-9 (C 
83.7), C-13, C-14, C-15 (C 16.8), and C-16, and from Me-10 to C-8. The relative configurations 
of C-7, C-8, and C-13 were assigned tentatively by the coupling constants of 10.7 and 8.1 Hz, 
suggesting -orientations of the attached protons as shown in Figure 2. The NOESY correlations 
(Figure 2) of H-7/H-8/Me-16, H-8/Me-10, H-8/H-13, and H-13/Me-16 supported the assignments. 
Compound 3 was also analyzed by chiral-phase HPLC, but only a single peak was observed. The 
structure of mallopenin C (3) was thus assigned as shown in Chart 1.  
Compound 4, characterized as a pale yellow viscous oil with [𝛼]D
25 -31.6 (c 0.2, MeOH), 
has a molecular formula of C22H22O5 based on the HRTOFESIMS (m/z 389.1375; calcd for 
389.1365, C22H22O5Na) and 
13C NMR data. The UV spectrum is typical of a flavanone 
chromophore with absorption bands at max 234, 264, 274, and 298 nm, while the IR absorption 
band at 1701 cm−1 implied a conjugated carbonyl moiety. The 1H NMR data (Table 2, Figure S27, 
Supporting Information) indicated the presence of a deshielded hydrogen-bonded hydroxy group 
(H 12.37), a monosubstituted aromatic ring [H 7.44 (5H)],  a 2,2-dimethyl-2H-pyran unit (H 
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6.64, 5.52, 1.47 and 1.44), an ABX spin system (H 5.45, 3.06 and 2.89), and a methoxy group (H 
3.35). The NMR data were similar to those of 6,6-dimethylpyrano[b,g]-5-hydroxy-8-
methylflavanone,11 except for the presence of two doublets of an oxygenated methylene group (H 
4.49 and 4.43) instead of a singlet for an aromatic methyl substituent. These proton resonances 
showed correlations with C-7 (C 160.9), C-8 (C 105.3), C-9 (C 161.0), and 11-OMe (C 57.9) 
in the HMBC spectrum (Figure 1), indicating their attachment at C-8. A negative Cotton effect at 
280 nm in the ECD spectrum defined the (2S) absolute configuration of 4.12 Thus, the structure of 
mallopenin D (4) was assigned as shown in Chart 1.  
Compound 5, a pale yellow solid, has a formula of C22H20O6 based on the HRTOFESIMS 
ion at m/z 381.1341 [M + H]+ (calcd for 381.1338) and the 13C NMR data. The UV and IR spectra 
were consistent with a flavanone skeleton.  Compound 5 had the same skeleton as 4, by 
comparison of their NMR data (Table 2, Figures S35 and S36, Supporting Information). The lack 
of the OMe resonance at H 3.35 indicated a presence of a hydroxycarbonyl group at C-11 
confirmed by the HMBC correlations (Figure 1) between H-11 and C-7 (C 159.2), C-8 (C 110.8), 
C-9 (C 159.5), and C-12 (C 176.5). The (2S) configuration of 5 was elucidated based on its ECD 
data. Therefore, the structure of mallopenin E (5) was identified as shown in Chart 1. 
Possible biosynthetic pathways for compounds 1-3 and 11 are illustrated in Scheme 1. 
These compounds could be obtained from a cinnamoyl-CoA starter and three malonyl-CoA 
extenders in a multi-step process.13 Epoxidation of metabolite i followed by ring closure and 
dehydration could yield chromene iv. The intramolecular cyclization of iv would give chalcone 1, 
which could undergo further C-C cleavage to form compound 2. A formal [2+2] cycloaddition 
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(possibly either photochemically induced or via a non-concerted process) of the precursor iv could 
produce compound 3. 
The MIC values of some isolated compounds against Gram-positive and Gram-negative 
bacteria are summarized in Table 3. Only compounds 6 and 7 showed significant antibacterial 
activities against M. luteus, S. mutans, B. cereus, S. aureus and E. coli with MIC values ranging 
from 3.8-15.5 μM. With MIC values of 30 μM, compounds 9 and 10 exhibited moderate activity 
against B. cereus, while compound 10 also showed moderate activity against all tested Gram-
positive strains. The remaining compounds showed weak or no activity. It is interesting to note 
that compound 7 with a hydroxy group at C-4 had better activity than 6, which lacked this 
substituent.  
EXPERIMENTAL SECTION 
General Experimental Procedures. The instruments and materials in this study were the 
same as previously described.14-16 
Plant Material. The fruits of M. philippensis were collected from Doi Tung (Chiang Rai 
Province, Thailand, GPS: 20°17.351ʹ N, 99°48.661ʹ E) in August 2015 and authenticated by Mr. 
Martin Van de Bult, Doi Tung Development Project. A specimen of the material (MFU-NPR0123) 
is stored at the Natural Products Research Laboratory, School of Science, Mae Fah Luang 
University. 
Extraction and Isolation. Ground dried fruits of M. philippensis (7.0 kg) were soaked 
with acetone (2 × 5 L, 3 days) and the mixture was concentrated under reduced pressure to afford 
the acetone extract (648.6 g). The extract was separated by quick column chromatography (QCC) 
using hexanes as eluent followed by gradient elution with increasing polarity with EtOAc (100:0 
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– 0:100) to give 10 fractions (Fr. 1–Fr. 10). Fraction Fr. 2 (8.05 g) was subjected to CC using 
EtOAc–hexanes (1:19) as mobile phase to afford eight subfractions (Fr. 2a–Fr. 2h). Compound 2 
(4.7 mg) was obtained from subfraction Fr. 2d (503.5 mg) by CC over Sephadex LH-20, with 
100% MeOH as mobile phase, followed by recrystallization with MeOH–CH2Cl2 (1:4). 
Subfraction Fr. 2e (1.17 g) was chromatographed by CC using EtOAc–hexanes (1:99) as mobile 
phase followed by CC over Sephadex LH-20, with MeOH–CH2Cl2 (1:1) as mobile phase to 
provide 3 (7.3 mg). Compound 1 (255.5 mg) was purified by recrystallization from MeOH–
CH2Cl2 (9:1) from fraction Fr. 4 (2.01 g). Fraction Fr. 5 (131.4 g) was subjected to CC with 
EtOAc–hexanes (0:100 –100:0) as mobile phase to give six subfractions (Fr. 5a – Fr. 5f). 
Subfraction Fr. 5d (50.8 mg) was separated by Sephadex LH-20 CC [eluted with MeOH–CH2Cl2 
(1:1)] to give eight subfractions (Fr. 5d1–Fr. 5d8). Purification of subfraction Fr. 5d2 (3.25 g) by 
CC using EtOAc–hexanes (1:19) as mobile phase and by CC over Sephadex LH-20, with MeOH–
CH2Cl2 (1:1) as mobile phase afforded 4 (11.2 mg), 6 (1.8 g), 7 (115.8 mg), 10 (89.8 mg) and 11 
(52.1 mg).  Fraction Fr. 6 (1.50 g) was chromatographed by CC eluting with EtOAc–hexanes (1:9) 
as mobile phase, followed by CC over RP-18 with MeOH–H2O (7:3) yielding 5 (4.8 mg), 8 (455.0 
mg) and 9 (43.7 mg). 
Mallopenin A (1): orange crystals; mp 188.1189.3 °C; [𝛼]D
25 0 (c 0.11, CHCl3); UV 
(MeOH) λmax (log ε) 236 (2.86), 307 (2.80), 351 (2.90) nm; IR (KBr) νmax 3327, 2968, 2932, 1691, 
1631, 1555, 1131, 1051, 947 cm−1; 1H and 13C NMR , see Table 1; HRESIMS [M]+ m/z 458.2452 
(calcd for 458.2457, C30H34O4).  
Chiral-phase HPLC Analysis and ECD Spectra of (+)-1 and (−)-1. The racemate 1 (4.0 
mg) was resolved by chiral-phase HPLC on a CHIRALCEL OD-H column, using n-
hexane−iPrOH (99:1) at 1.5 mL/min. Compound (+)-1 (tR = 12.5 min) [(1.6 mg), [𝛼]D
24 +28.4 (c 
 
 
10 
 
0.03, CHCl3)]; ECD (c 4.0 × 10−4 M, MeOH) λmax (Δε); 224 (−5.01 × 10−1), 245 (+1.93 × 10−1), 
304 (+1.10 × 10−1)  and 363 (−1.51× 10−1) nm] and (−)-1 (tR =14 min) [(1.5 mg), [𝛼]D
24 −24.6 (c 
0.03, CHCl3)]; ECD (c 7.0 × 10
−4 M, MeOH) λmax (Δε); 222 (+8.93), 246 (−2.07 × 10
−1), 302 
(−8.73)  and 366 (+1.57 × 10−1) nm] were obtained. 
Mallopenin B (2): pale yellow solid; mp 129.5130.0 °C; [𝛼]D
25 0 (c 0.07, CHCl3); UV 
(MeOH) λmax (log ε) 217 (3.92), 302 (2.58), 354 (2.13) nm; IR (neat) νmax 3282, 2923, 1713, 1596, 
1494, 1156, 1081, 811, 664 cm−1; 1H and 13C NMR, see Table 1; HRESIMS [M + H]+ m/z 
371.2216 (calcd for 371.2222, C23H31O4).  
Chiral-phase HPLC Analysis and ECD Spectra of (+)-2 and (−)-2. The racemate 2 (3.0 
mg) was resolved by chiral-phase HPLC on a CHIRALCEL OD-H column, using n-
hexane−iPrOH (99:1) at 1.0 mL/min. Compound (+)-2 (tR = 13.0 min) [(1.1 mg), [𝛼]D
24 +17.4 (c 
0.02, CHCl3)]; ECD (c 1.0 × 10−3 M, MeOH) λmax (Δε); 275 (+1.62 × 10−1), 316 (−7.48) and 355 
(−1.05 × 10−1) nm] and (−)-2 (tR = 13.5 min) [(1.0 mg), [𝛼]D
24 −11.8 (c 0.02, CHCl3)]; ECD (c 2.1 
× 10−3 M, MeOH) λmax (Δε); 273 (−1.34 × 10
−1), 319 (+9.98) and 352 (+1.09 × 10−1) nm] were 
obtained. 
Mallopenin C (3): pale yellow solid; mp 134.7136.2 °C; [𝛼]D
24 +7.6 (c 0.02, MeOH); UV 
(MeOH) λmax (log ε) 220 (4.12), 301 (2.36), 350 (2.31) nm; IR (KBr) νmax 3325, 3191, 2961, 1675, 
1622, 1517, 1201, 1109, 742 cm−1; 1H and 13C NMR, see  Table 1; HRTOFESIMS [M + H]+ m/z 
459.2505 (calcd for 459.2535, C30H34O4).  
Mallopenin D (4): pale yellow solid; mp 144.5145.8 °C; [𝛼]D
25 -31.6 (c 0.2, MeOH); ECD 
(c 0.5 ×10-4) λmax (∆ε) 280 (‒1.05) nm; UV (MeOH) λmax (log ε) 234 (3.46), 264 (4.12), 274 (4.31), 
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298 (2.96) nm; IR (KBr) νmax 2917, 1701, 1629, 1584, 1246, 1067, 943 cm
−1; 1H and 13C NMR, 
see Table 2; HRTOFESIMS [M + Na]+ m/z 389.1375 (calcd for 389.1365, C22H22O5Na).  
Mallopenin E (5): pale yellow solid; mp 215.9217.3 °C; [𝛼]D
21 −23.5 (c 0.23, EtOH); 
ECD (c 1.8 ×10-3) λmax (∆ε) 272 (‒2.06), 297 (+0.43) nm; UV (EtOH) λmax (log ε) 305 (3.02), 297 
(4.71) nm; IR (KBr) νmax 3490, 3020, 2976, 2930, 1709, 1624, 1445, 1128, 755, 699 cm
−1; 1H  and 
13C NMR, see Table 2; HRTOFESIMS [M + H]+ m/z 381.1341 (calcd for 381.1338, C22H20O6).  
X-ray Crystallographic Analysis of (+)-1. The measurement of (+)-1 was performed on 
a Bruker APEX-II CCD diffractometer with Cu Kα radiation (λ = 1.54178 Å). The structure was 
solved and refined using the Bruker SHELXTL Software Package. Crystal data for (+)-1: 
C30H34O4, Mr = 458.57, orthorhombic, P212121 (No. 19), a = 7.8303(2) Å, b = 10.9599(2) Å, c = 
28.0066(6) Å, α = β = γ = 90°, V = 2403.51(9) Å3, T = 90(2) K, Z = 4, Z' = 1, (CuKα) = 0.655, 
26458 reflections measured, 4384 unique (Rint = 0.0395) which were used in all calculations. The 
final wR2 was 0.0790 (all data) and R1 was 0.0314 (I > 2(I)). The Flack parameter value was 
0.06(7). Crystallographic data for (+)-1 have been deposited at the Cambridge Crystallographic 
Data Centre (no. CCDC 1896823). These data can be obtained free of charge via the Internet at 
www.ccdc.cam.ac.uk/data_request/cif. 
Antibacterial Assay. MIC assessments were carried out following the CLSI guidelines by 
broth microdilution in 96-well microtiter plates that was described in detail previously.16-18  
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Chart 1 
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Figure 1. 1H → 1H COSY and key HMBC (1H → 13C) correlations of 1−5. 
 
 
Figure 2. Selected NOSEY correlations of (+)-1 and 3. 
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Figure 3. ORTEP diagram for (+)-1. 
 
 
Figure 4. Experimental ECD spectra of compound (+) and (−)-1, and (+) and (−)-2. 
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Scheme 1. Putative Biosynthetic Pathways for 1-3 and 11. 
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Table 1. 1H (400 MHz, CDCl3) and 
13C NMR (100 MHz, CDCl3) Spectroscopic Data of 1-3  
position 1  2  3a 
C H (mult., J in Hz)  C H (mult., J in Hz)  C H (mult., J in Hz) 
1 106.5   106.1   106.2  
2 163.8   162.7   161.8  
3 111.5   110.5   104.6  
4 161.1   160.9   159.5  
5 106.4   106.0   102.4  
6 156.4   156.7   156.6  
7 27.8 2.84, br s  27.7 2.80, br s  34.7 3.00, d (10.7) 
8 35.3 2.25, dt (12.8, 3.5) 
1.89, dd (12.8, 1.1) 
 34.9 2.19, m 
1.84, m 
 36.5 2.60, dd (10.7, 8.1) 
9 76.3   76.1   83.7  
10 29.1 1.53, s  28.9 1.43, s  26.7 1.41, s 
11 37.6 1.85, m 
1.46, m 
 37.7 1.81, m 
1.49, m 
 37.6 2.04, m 
1.67, m 
12 22.1 1.33, m 
0.92, m 
 22.1 1.30, m 
0.87, m 
 24.8 1.67, m 
1.58, m 
13 46.0 2.04, m  46.0 2.03, m  45.2 2.34, br t (8.1) 
14 84.9   84.8   38.2  
15 24.4 1.08, s  24.4 1.05, s  16.8 0.70, s 
16 29.8 1.56, s  29.8 1.56, s  32.6 1.29, s 
17 192.2   202.8   192.2  
18 128.0 8.12, d (15.6)  32.5 2.61, s  127.3 7.80, d (15.7) 
19 141.4 7.77, d (15.6)     140.1 7.66, d (15.7) 
1 21.3 3.25, m  21.3 3.22, m  20.7 3.39, dd (16.4, 6.7) 
3.30, dd (16.4, 7.1) 
2 123.2 5.21, br t (7.0)  123.2 5.18, br s   120.8 5.19, br t (7.1) 
3 130.9   130.9   135.1  
4 17.9 1.79, s  17.8 1.77, s  16.9 1.76, s 
5 25.8 1.67, s  25.8 1.65, s  24.8 1.71, s 
1 135.9      134.9  
2/6 128.3 7.60, m     127.2 7.53, m 
3/5 128.9 7.38, m     127.9 7.32, m 
4 128.8 7.38, m     128.7 7.32, m 
4-OH        6.00, s 
2-OH  14.39, s   13.88, s   14.21, s 
 
aRecorded at 500 MHz.   
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Table 2. 1H (400 MHz, CDCl3) and 
13C NMR (100 MHz, CDCl3) Spectroscopic Data of 4 and 5  
position 4  5a 
C H (mult., J in Hz)  C H (mult., J in Hz) 
2 78.9 5.45, br d (12.9)  78.6 5.44, dd (12.9, 3.0) 
3 43.2 3.06, dd (16.7, 12.9) 
2.89, dd (16.7, 3.0) 
 42.9 3.06, dd (17.1, 12.9) 
2.86, dd (17.1, 3.0) 
4 196.2   195.6  
5 158.3   157.2  
6 102.9   102.2  
7 160.9   159.2  
8 105.3   110.8  
9 161.0   159.5  
10 102.5   102.4  
11 61.8 4.49, d (11.0) 
4.43, d (11.0) 
 27.3 3.63, s 
12    176.5  
1 138.6   137.9  
2/6 125.9 7.44, m  125.4 7.42, m 
3/5 128.8 7.44, m  128.4 7.42, m 
4 128.6 7.44, m  128.3 7.42, m 
1 115.5 6.64, d (9.1)  114.9 6.65, d (10.1) 
2 126.3 5.53, d (9.1)  125.7 5.52, d (10.1) 
3 78.6   78.5  
4 28.3 1.47, s  27.9 1.43, s 
5 28.3 1.45, s  28.0 1.44, s 
5-OH  12.37, s   12.30, s 
11-OMe 57.9 3.35, s    
 
aRecorded at 600 MHz. 
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Table 3. Antibacterial Activity of Compounds 2-11 
Compound 
MIC (μM) 
Gram-positive bacteria  Gram-negative bacteria 
M. 
luteus 
S. 
mutans 
S. 
epidermidis 
B. 
cereus 
S. 
aureus 
 
S. 
typhimurium 
Ps. 
aeuruginosa 
E. coli 
S. 
flexneri 
  ()-2 > 100 > 100 > 100 > 100 > 100  > 100 > 100 > 100 > 100 
3 > 100 > 100 > 100 > 100 > 100  > 100 > 100 > 100 > 100 
4 > 100 > 100 > 100 > 100 > 100  > 100 > 100 > 100 > 100 
5 > 100 > 100 > 100 > 100 > 100  > 100 > 100 > 100 > 100 
6 15.5 15.5 > 100 15.5 15.5  > 100 > 100 15.5 > 100 
7 30.1 3.8 > 100 3.8 15.0  > 100 > 100 7.5 > 100 
8 > 100 > 100 > 100 > 100 > 100  > 100 > 100 > 100 > 100 
9 > 100 > 100 > 100 30.1 > 100  > 100 > 100 > 100 > 100 
10 30.9 30.9 > 100 30.9 61.8  > 100 > 100 30.9 > 100 
11 > 100 > 100 > 100 > 100 > 100  > 100 > 100 > 100 > 100 
Vancomycin 0.2 0.2 0.2 0.1 0.2      
Gentamicin       1.0 1.0 0.5 1.0 
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